From: Changes in fibrinogen availability and utilization in an animal model of traumatic coagulopathy
Base line | 0 minutes | 30 minutes | 60 minutes | ||
---|---|---|---|---|---|
MAP | TS | 125.3 (23.9) | 71.6 (18.2)* | 36.2 (3.0)*† | 36.8 (5.6)*† |
T | 122.3 (10.3) | 66.7 (8.14)* | 70.3 (14.1)* | 68.3 (13.5)* | |
S | 94.8 (27.0) | 44.8 (4.0)*† | 53.3 (8.2)*† | ||
C | 120.0 (7.8) | 85.5(7.8)* | 85.0 (7.0)* | ||
HR | TS | 85.3 (4.7)† | 95.3 (12.1) | 96.4 (12.0) | 99.2 (17.6) |
T | 91.3 (7.0) | 92.0 (10.2) | 88.5 (12.1) | 87.6 (13.6) | |
S | 106.0 (12.1)† | 91.8 (9.6) | 92.3 (11.7) | ||
C | 101.0 (5.0) | 116.0 (7.1) | 106.5 (2.1) | ||
BE | TS | 7.88 (2.49) | 6.88 (2.44) | 4.18 (4.24) | 1.27 (3.63)*† |
T | 9.38 (5.17) | 7.85 (0.72) | 6.10 (2.82) | 6.65 (0.65) | |
S | 7.70 (1.43) | 6.35 (1.13) | 6.65 (0.65)† | ||
C | 9.30 (0.42) | 10.25 (1.63) | 9.00 (0.99) |